Verso
Clinical Trials

Verso Skincare has, among other trials, been clinically tested in a double blind, placebo controlled split face study under supervision of Dr. Margareta Frohm Nilsson at the Karolinska University Hospital, Stockholm, Sweden.

Study Results


In the first twelve weeks of use, 100% of the participants in the trial group experienced an overall improvement in their skin. The second twelve weeks showed 82% of people gaining more lustrous skin and 77% of the group feeling an overall improvement compared to the first twelve week period.

“Verso has been studied in a comprehensive clinical trial. My experience from this study is that Retinol 8 does not show any side effects and seems to be effective when treating lines, age spots, and dull skin tone. Effects may appear rather soon but will usually become apparent gradually.”

Statement from Dr. Margareta Frohm Nilsson, Karolinska University Hospital, Stockholm, Sweden.

References on published data on active ingredients 
is available upon request.